PharMolix Inc. is an AI and Biotechnology company dedicated to transforming the biomedical industry through multimodal AI foundation models and intelligent agents. The company comprises top scientists and leaders from both AI and biomedical domains. PharMolix has developed the world's first 100B multi-modal biomedical AI foundation model, and the next generation conversational drug discovery assistant, ChatDD (Chat for Drug Discovery & Development). ChatDD combines human expert knowledge with insights from multi-modal AI foundation models, enabling a new paradigm of drug R&D. The product is used in pharmaceutical business Intelligence, drug discovery, clinical trials, among others. PharMolix is named the recipient of the 2024 BEYOND Healthcare Innovation Award, and among the 2024 Top 30 AI Innovative companies (by InvestorsCN) and the 2023 Top 10 ScienceAI companies in China. PharMolix is backed by premier venture capital firms in the industry.
| Employees | 7 (6 on RocketReach) |
| Founded | 2023 |
| Industry | Technology, Information and Internet |
Looking for a particular PharMolix employee's phone or email?
PharMolix Questions
Mu Qiao is the Co-Founder and Chief Technology Officer of PharMolix.
6 people are employed at PharMolix.
Top PharMolix Employees
-
Mu Qiao
Co-Founder and Chief Technology Officer at PharMolix
San Jose, CA, US -
Regina Lin
Head of Business Development at PharMolix
Shanghai, China1 -
Jerry Xing
COO at PharMolix
Shanghai, CN -
Shunji Wan
Software Engineer at PharMolix
Beijing, China2
